CoTherix's P2P Acquisition

CoTherix raised a round of funding on January 09, 2007. Investors include Actelion.

CoTherix is dedicated to the development and commercialization of improved therapies for inflammatory lung diseases. The company was formed in 2000 with the initial focus of commercializing a decade o…

Articles about CoTherix's P2P Acquisition: